期刊文献+

达英-35治疗青春期功血的临床分析 被引量:5

Clinical Analysis on Adolescent Dysfunctional Uterine Bleeding Therapy with Ethinylestradiol and Cyproterone Acetate Tablets
下载PDF
导出
摘要 目的探讨达英-35治疗青春期功血的临床疗效。方法 54例青春期功血患者随机分为用达英-35治疗的观察组(35例)和用雌孕激素联合治疗的对照组(19例),比较2组的临床疗效。结果 2组患者治疗效果、完全控制出血时间及完全止血时间差别无统计学意义,止血后2组再次发生出血及不良反应发生的情况,观察组明显少于对照组,P<0.05,差别有统计学意义。结论达英-35治疗青春期功血疗效好、服用简单、不良反应少、易于被患者接受。 Objective To explore Ethinylestradiol and Cyproterone Acetate Tablets of the clinical efficacy of adolescent dysfunclional uterine bleeding.Methods 54 patients with adolescent dysfunctional uterine bleeding were randomly divided into observtion group(35 cases)and control group(19cases).The clinical effects of the two groups were compared and analyzed.Results The two groups of patients with clinical effect,complete control of bleeding time and complete stop of bleeding lime was no significant difference between the two groups.The incidence rate of bleeding again and adverse effect in observtion group was less than control group(P〈0.05).Conclusion Ethinylestradiol and Cyproterone Acetate Tablets shows significant therapeutic effect on adolescent dysfunctional uterine bleeding.It is convenient for administration with less toxic side effect and is acceptable to patients.
作者 饶琪
出处 《中国卫生产业》 2011年第9期37-38,40,共3页 China Health Industry
关键词 达英-35 雌孕激素联合治疗 青春期功血 Ethinylestradiol and Cyproterone Acetate Tablets The combination of estrogen and progesterone treatment Adolescent dysfunctional uterine bleeding
  • 相关文献

参考文献5

二级参考文献27

  • 1陈晓燕.妈富隆治疗绝经过渡期功血52例分析[J].国外医学(妇幼保健分册),2005,16(2):125-126. 被引量:3
  • 2张丽敦,刘甲炎.妈富隆用于青春期功血止血治疗的探讨[J].广西医学,2005,27(11):1770-1771. 被引量:14
  • 3杨东霞,曲凡,马文光,马宝璋.中西药结合治疗青春期功能失调性子宫出血89例[J].中国妇幼保健,2007,22(25):3597-3598. 被引量:19
  • 4张以文 曹泽毅.功能失调性子宫出血.中华妇产科学(下册)[M].北京:人民卫生出版社,1999.2118.
  • 5Taylor RN,Lebovic DI,Hornung D,et al.Endocrine and paracrine regulation of endometrial angiogenesis.Ann N Y.Acad Sci,2001,943:109-121.
  • 6Kooy J,Taylor NH,Healy DL,et al.Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.Hum Reprod,1996,11(5):1067-1072
  • 7Rogers PA,Lederman F,Taloy N.Endometrial microvascular growth in normal and dysfunctional states.Hum Reprod Update,1998,4(5):503-508
  • 8Abberton KM,Taylor NH,Healy DL,et al.Vascular smooth muscle cell proliferation in arterioles of the human endometrium.Hum Reprod,1999,14(4):1072-1079
  • 9Sangha RK,Li XF,Shams M,et al.Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling:localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia.Lab Invest,1997,77(4):389-402
  • 10Meduri G,Bausero P,Perrot-Applanat M.Expression of vascular endothelial growth factor receptors in the human endometrium:modulation during the menstrual cycle.Biol Reprod,2000,62(2):439-447

共引文献97

同被引文献30

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部